The Japan Society of Hepatology has raised awareness of steatotic liver disease and issued the “Nara Declaration 2023,”5 recommending that individuals with alanine aminotransferase (ALT) levels of ≥30 IU/L consult their physician. Here, GPT is linked to liver disorder.